AMGN:NGS-Amgen Inc. (USD)

EQUITY | Drug Manufacturers - General | Nasdaq Global Select

Last Closing

USD 332.47

Change

-0.81 (-0.24)%

Market Cap

USD 107.37B

Volume

2.12M

Analyst Target

USD 262.76
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Amgen Inc is a biotechnology company that discovers, develops, manufactures and delivers human therapeutics. The Company's business segment is human therapeutics.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-31 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
AZN AstraZeneca PLC ADR

N/A

USD 257.50B
SNY Sanofi ADR

N/A

USD 141.45B
GILD Gilead Sciences Inc

N/A

USD 98.52B
BIIB Biogen Inc

N/A

USD 29.85B
GRFS Grifols SA ADR

N/A

USD 6.95B
AMRN Amarin Corporation PLC

N/A

USD 0.25B
MIRA MIRA Pharmaceuticals, Inc. Com..

N/A

USD 0.02B
SCLX Scilex Holding Company

N/A

N/A
SCLXW Scilex Holding Company

N/A

N/A

ETFs Containing AMGN

BTEC:SW iShares Nasdaq US Biotech.. 7.89 % 0.00 %

N/A

N/A
UBIO 6.41 % 0.95 %

N/A

N/A
MEDX Horizon Kinetics Medical .. 5.91 % 0.00 %

N/A

N/A
LIFE-B:CA Evolve Global Healthcare .. 5.45 % 0.00 %

N/A

N/A
ZWA:CA BMO Covered Call Dow Jone.. 5.39 % 0.72 %

N/A

CAD 0.20B
ZDJ:CA BMO Dow Jones Industrial .. 5.33 % 0.26 %

N/A

CAD 0.41B
CSINDU:SW iShares VII PLC - iShares.. 5.32 % 0.00 %

N/A

USD 1.19B
DJIA Global X Dow 30 Covered C.. 5.28 % 0.00 %

N/A

USD 0.09B
FHI:CA CI Health Care Giants Cov.. 5.25 % 0.75 %

N/A

CAD 0.09B
FHI-B:CA CI Health Care Giants Cov.. 5.25 % 0.00 %

N/A

CAD 0.05B
THNR Amplify ETF Trust 5.12 % 0.00 %

N/A

N/A
ZWHC:CA BMO Covered Call Health C.. 5.07 % 0.00 %

N/A

N/A
DIVO Amplify CWP Enhanced Divi.. 5.02 % 0.94 %

N/A

USD 3.40B
DOGG 4.95 % 0.00 %

N/A

N/A
NDJI 4.95 % 0.00 %

N/A

N/A
LIFE:CA Evolve Global Healthcare .. 4.94 % 0.69 %

N/A

CAD 0.22B
LIFE-U:CA Evolve Global Healthcare .. 4.94 % 0.00 %

N/A

N/A
YALL God Bless America ETF 4.70 % 0.00 %

N/A

N/A
OZEM Roundhill GLP-1 & Weight .. 4.60 % 0.00 %

N/A

N/A
NUSA:CA NBI Active U.S. Equity ET.. 4.58 % 0.00 %

N/A

CAD 0.05B
XSGI:SW Xtrackers S&P Global Infr.. 4.51 % 0.00 %

N/A

USD 0.25B
CBUF:F iShares V Public Limited .. 4.40 % 0.00 %

N/A

N/A
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.39 % 0.00 %

N/A

USD 0.15B
GDOC Goldman Sachs ETF Trust 4.24 % 0.00 %

N/A

USD 0.02B
WHCS:SW iShares MSCI World Health.. 4.21 % 0.00 %

N/A

N/A
SCHD Schwab U.S. Dividend Equi.. 3.99 % 0.07 %

N/A

USD 60.62B
ESGI:AU VanEck MSCI International.. 3.70 % 0.00 %

N/A

USD 0.19B
PWV Invesco Dynamic Large Cap.. 3.47 % 0.55 %

N/A

USD 1.00B
WH2E:XETRA Invesco Markets II plc - .. 3.35 % 0.00 %

N/A

USD 0.07B
SXLV:SW SPDR S&P U.S. Health Care.. 3.23 % 0.00 %

N/A

N/A
FDV First Trust Capital Stren.. 3.17 % 0.00 %

N/A

N/A
XUHC:SW Xtrackers MSCI USA Health.. 3.12 % 0.00 %

N/A

USD 0.65B
IUHC:SW iShares S&P 500 Health Ca.. 3.12 % 0.00 %

N/A

N/A
GXLV:LSE SPDR® S&P® U.S. Health .. 3.11 % 0.00 %

N/A

N/A
UDOW ProShares UltraPro Dow30 3.10 % 0.95 %

N/A

USD 0.64B
XLV Health Care Select Sector.. 3.09 % 0.13 %

N/A

USD 42.49B
HEAL:CA 2.96 % 0.00 %

N/A

N/A
NZRO 2.90 % 0.00 %

N/A

N/A
CURE:AU ETFS S&P Biotech ETF 2.78 % 0.00 %

N/A

USD 0.04B
EQIN Russell Equity Income ETF 2.51 % 0.00 %

N/A

N/A
HLTH:AU VanEck Global Healthcare .. 2.49 % 0.00 %

N/A

USD 0.06B
UVDV 2.35 % 0.00 %

N/A

N/A
TDOC:CA TD Global Healthcare Lead.. 2.34 % 0.00 %

N/A

CAD 0.09B
DSTL Distillate US Fundamental.. 1.82 % 0.00 %

N/A

USD 1.96B
USRI:LSE 1.80 % 0.00 %

N/A

N/A
ZUH:CA BMO Equal Weight US Healt.. 1.76 % 0.39 %

N/A

CAD 0.28B
LABU Direxion Daily S&P Biotec.. 1.73 % 1.14 %

N/A

USD 1.01B
XLVE:CA Mulvihill U.S. Health Car.. 1.72 % 0.00 %

N/A

N/A
ZDY.U:CA 1.63 % 0.33 %

N/A

N/A
HEAL:SW iShares Healthcare Innova.. 1.61 % 0.00 %

N/A

N/A
HYLG Global X Funds - Global X.. 1.45 % 0.00 %

N/A

N/A
ESMV iShares ESG MSCI USA Min .. 1.45 % 0.00 %

N/A

USD 0.01B
CSY9:XETRA UBS (Irl) ETF plc - Facto.. 1.45 % 0.00 %

N/A

USD 0.29B
WDMVO:SW UBS (Irl) ETF plc - Facto.. 1.45 % 0.00 %

N/A

N/A
LESW:LSE 1.25 % 0.00 %

N/A

N/A
WEBA:XETRA Amundi US Tech 100 Equal .. 1.23 % 0.00 %

N/A

USD 0.60B
SF1CHA:SW 1.09 % 0.00 %

N/A

N/A
F1ESG:SW UBS(Lux)Fund Solutions .. 1.09 % 0.00 %

N/A

N/A
BBH VanEck Biotech ETF 0.00 % 0.35 %

N/A

USD 0.45B
BIB ProShares Ultra Nasdaq Bi.. 0.00 % 0.95 %

N/A

USD 0.09B
BIS ProShares UltraShort Nasd.. 0.00 % 0.95 %

N/A

USD 3.31M
CURE Direxion Daily Healthcare.. 0.00 % 1.06 %

N/A

USD 0.21B
DDM ProShares Ultra Dow30 0.00 % 0.95 %

N/A

N/A
DEW WisdomTree Global High Di.. 0.00 % 0.58 %

N/A

N/A
DIA SPDR Dow Jones Industrial.. 0.00 % 0.17 %

N/A

N/A
DJD Invesco Dow Jones Industr.. 0.00 % 0.09 %

N/A

N/A
ESGS 0.00 % 0.35 %

N/A

N/A
FBT First Trust NYSE Arca Bio.. 0.00 % 0.57 %

N/A

N/A
FHLC Fidelity® MSCI Health Ca.. 0.00 % 0.08 %

N/A

USD 3.19B
IBB iShares Biotechnology ETF 0.00 % 0.47 %

N/A

USD 7.71B
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

N/A

N/A
LABS 0.00 % 0.45 %

N/A

N/A
LNGR 0.00 % 0.50 %

N/A

N/A
PBE Invesco Dynamic Biotechno.. 0.00 % 0.57 %

N/A

N/A
PJP Invesco Dynamic Pharmaceu.. 0.00 % 0.56 %

N/A

N/A
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

N/A

USD 0.02B
HONR 0.00 % 0.65 %

N/A

N/A
VSL 0.00 % 0.65 %

N/A

N/A
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

N/A

N/A
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

N/A

N/A
SICK 0.00 % 0.95 %

N/A

N/A
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

N/A

N/A
XBI SPDR® S&P Biotech ETF 0.00 % 0.35 %

N/A

N/A
ZBIO 0.00 % 0.95 %

N/A

N/A
HHL:CA Harvest Healthcare Leader.. 0.00 % 1.15 %

N/A

N/A
CIND:LSE iShares VII PLC - iShares.. 0.00 % 0.00 %

N/A

USD 1.20B
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

N/A
IUHC:LSE iShares S&P 500 USD Healt.. 0.00 % 0.00 %

N/A

USD 2.48B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

N/A
VMVL:LSE 0.00 % 0.00 %

N/A

N/A
WQDS:LSE iShares MSCI World Qualit.. 0.00 % 0.00 %

N/A

N/A
WQDV:LSE iShares MSCI World Qualit.. 0.00 % 0.00 %

N/A

N/A
XLDX:LSE Xtrackers LevDAX Daily Sw.. 0.00 % 0.00 %

N/A

N/A
XSGI:LSE Xtrackers S&P Global Infr.. 0.00 % 0.00 %

N/A

USD 0.25B
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.66B
XUHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.66B
2B70:F iShares NASDAQ US Biotech.. 0.00 % 0.00 %

N/A

USD 0.52B
EXI3:F iShares Dow Jones Industr.. 0.00 % 0.00 %

N/A

N/A
GNAR:F 0.00 % 0.00 %

N/A

N/A
MJMT:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

N/A
QDVW:F iShares MSCI World Qualit.. 0.00 % 0.00 %

N/A

N/A
SXRU:F iShares Dow Jones Indust .. 0.00 % 0.00 %

N/A

USD 1.20B
XAMB:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
XUHC:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

N/A

USD 0.85B
ZPDH:F SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

USD 0.40B
2B70:XETRA iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

USD 0.52B
DX2E:XETRA Xtrackers - S&P Global In.. 0.00 % 0.00 %

N/A

USD 0.21B
EXI3:XETRA iShares Dow Jones Industr.. 0.00 % 0.00 %

N/A

USD 0.30B
GNAR:XETRA 0.00 % 0.00 %

N/A

N/A
QDVG:XETRA iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

USD 2.05B
SXRU:XETRA iShares VII PLC - iShares.. 0.00 % 0.00 %

N/A

USD 1.16B
VMVL:XETRA 0.00 % 0.00 %

N/A

N/A
XUHC:XETRA Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.85B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

USD 0.40B
1546:TSE NEXT FUNDS DJIA (Yen-UnHe.. 0.00 % 0.00 %

N/A

USD 19.52B
TQGD:CA TD Q Global Dividend ETF 0.00 % 0.00 %

N/A

CAD 0.19B
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
FLXX:LSE Franklin LibertyQ Global .. 0.00 % 0.00 %

N/A

USD 0.08B
FRGD:LSE Franklin LibertyQ Global .. 0.00 % 0.00 %

N/A

USD 0.08B
ESNG 0.00 % 0.00 %

N/A

N/A
BMED BlackRock Future Health E.. 0.00 % 0.00 %

N/A

USD 4.21M
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

N/A

USD 1.13B
AGNG Global X Aging Population.. 0.00 % 0.00 %

N/A

USD 0.06B
IBBQ Invesco Nasdaq Biotechnol.. 0.00 % 0.00 %

N/A

USD 0.04B
WELG:XETRA Amundi S&P Global Health .. 0.00 % 0.00 %

N/A

N/A
WELS:XETRA Amundi S&P Global Health .. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.43% 80% B- 77% C+
Dividend Return 1.56% 50% F 46% F
Total Return 17.00% 80% B- 77% C+
Trailing 12 Months  
Capital Gain 44.29% 100% F 88% B+
Dividend Return 3.80% 75% C 61% D-
Total Return 48.10% 100% F 89% A-
Trailing 5 Years  
Capital Gain 77.58% 86% B+ 79% B-
Dividend Return 19.83% 80% B- 78% C+
Total Return 97.41% 100% F 82% B
Average Annual (5 Year Horizon)  
Capital Gain 7.38% 89% A- 64% D
Dividend Return 10.55% 89% A- 67% D+
Total Return 3.17% 60% D- 68% D+
Risk Return Profile  
Volatility (Standard Deviation) 14.30% 78% C+ 83% B
Risk Adjusted Return 73.79% 89% A- 90% A-
Market Capitalization 107.37B 88% B+ 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Drug Manufacturers - General) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 47.61 57% 21%
Price/Book Ratio 22.99 13% 5%
Price / Cash Flow Ratio 21.11 63% 14%
Price/Free Cash Flow Ratio 13.31 50% 21%
Management Effectiveness  
Return on Equity 72.57% 100% 99%
Return on Invested Capital 11.92% 88% 81%
Return on Assets 4.88% 75% 85%
Debt to Equity Ratio 1,013.64% 17% 2%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.